HRGN (HRGN) Stock Analysis
Verdict: AVOID
Severe liquidity strain with ~4 months cash runway and 0.26 current ratio poses acute dilution risk despite recent $704k revenue entry.
Investment score: 30/100
The AI model identifies acute liquidity distress and imminent equity dilution risk for HRGN, given $1.35M in cash versus a $3.83M annual burn rate. High valuation metrics (P/S 47.07x) and weak balance sheet metrics outweigh recent technical momentum.
Peers
| Peer | P/E | P/B | P/S | EV/EBITDA | ROIC % | Net margin % |
|---|---|---|---|---|---|---|
| HOWL | -1.27 | 2.78 | 2.16 | -1.06 | — | -1.65 |
| ANVS | -0.62 | -9.79 | 0.00 | -0.58 | — | 0.00 |
| MGX | -0.47 | 0.39 | 3.22 | -0.48 | — | -6.89 |
| MCRB | -1.83 | 1.23 | 22.71 | -1.89 | — | -11.93 |
| CLCS | -5.75 | -1.39 | 0.00 | -18.93 | — | 0.00 |